[
    [
        "A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Research on Atezolizumab (MPDL3280A) Versus Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC Patients [IMpower110]",
        "Comparison of Atezolizumab (MPDL3280A) and Platinum-Based Chemotherapy (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]"
    ],
    [
        "A Study of Atezolizumab (MPDL3280A) Versus Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Research Comparing Atezolizumab (MPDL3280A) and Platinum-Based Chemotherapy (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Study on Atezolizumab (MPDL3280A) Compared to Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]"
    ],
    [
        "Atezolizumab (MPDL3280A) Study Compared With Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Study of Atezolizumab (MPDL3280A) Versus Platinum-Based Chemotherapy (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Research on Atezolizumab (MPDL3280A) Compared to Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]"
    ],
    [
        "Comparison Study of Atezolizumab (MPDL3280A) and Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Atezolizumab (MPDL3280A) Versus Platinum-Based Chemotherapy (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Study Comparing Atezolizumab (MPDL3280A) and Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]"
    ],
    [
        "Atezolizumab (MPDL3280A) Study Versus Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Research Comparing Atezolizumab (MPDL3280A) and Platinum-Based Chemotherapy (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Study of Atezolizumab (MPDL3280A) Compared With Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]"
    ],
    [
        "A Study of Atezolizumab (MPDL3280A) Versus Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Research on Atezolizumab (MPDL3280A) Compared to Platinum-Based Chemotherapy (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Comparison of Atezolizumab (MPDL3280A) and Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]"
    ],
    [
        "Atezolizumab (MPDL3280A) Study Compared With Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Study of Atezolizumab (MPDL3280A) Versus Platinum-Based Chemotherapy (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Research on Atezolizumab (MPDL3280A) Compared to Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]"
    ],
    [
        "Comparison Study of Atezolizumab (MPDL3280A) and Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Atezolizumab (MPDL3280A) Versus Platinum-Based Chemotherapy (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Study Comparing Atezolizumab (MPDL3280A) and Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]"
    ],
    [
        "Atezolizumab (MPDL3280A) Study Versus Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Research Comparing Atezolizumab (MPDL3280A) and Platinum-Based Chemotherapy (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Study of Atezolizumab (MPDL3280A) Compared With Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]"
    ],
    [
        "A Study of Atezolizumab (MPDL3280A) Versus Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Research on Atezolizumab (MPDL3280A) Compared to Platinum-Based Chemotherapy (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]",
        "Comparison of Atezolizumab (MPDL3280A) and Platinum Agents (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Stage IV Non-Squamous or Squamous NSCLC [IMpower110]"
    ]
]
